Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

1.

QEEG Measures in Huntington's Disease: A Pilot Study.

Hunter A, Bordelon Y, Cook I, Leuchter A.

PLoS Curr. 2010 Oct 25;2:RRN1192. doi: 10.1371/currents.RRN1192.

PMID:
21037796
[PubMed]
Free PMC Article
2.

Tongue force analysis assesses motor phenotype in premanifest and symptomatic Huntington's disease.

Reilmann R, Bohlen S, Klopstock T, Bender A, Weindl A, Saemann P, Auer DP, Ringelstein EB, Lange HW.

Mov Disord. 2010 Oct 15;25(13):2195-202. doi: 10.1002/mds.23243.

PMID:
20645403
[PubMed - indexed for MEDLINE]
3.

Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.

Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA, Borowsky B, Landwehrmeyer B, Frost C, Johnson H, Craufurd D, Reilmann R, Stout JC, Langbehn DR; TRACK-HD Investigators.

Lancet Neurol. 2013 Jul;12(7):637-49. doi: 10.1016/S1474-4422(13)70088-7. Epub 2013 May 9.

PMID:
23664844
[PubMed - indexed for MEDLINE]
4.

Severity of cognitive impairment in juvenile and late-onset Huntington disease.

Gómez-Tortosa E, del Barrio A, García Ruiz PJ, Pernaute RS, Benítez J, Barroso A, Jiménez FJ, García Yébenes J.

Arch Neurol. 1998 Jun;55(6):835-43.

PMID:
9626775
[PubMed - indexed for MEDLINE]
5.

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.

Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G, Jones R, Johnson H, Craufurd D, Hicks SL, Kennard C, Landwehrmeyer B, Stout JC, Borowsky B, Scahill RI, Frost C, Langbehn DR; TRACK-HD investigators.

Lancet Neurol. 2012 Jan;11(1):42-53. doi: 10.1016/S1474-4422(11)70263-0. Epub 2011 Dec 2.

PMID:
22137354
[PubMed - indexed for MEDLINE]
6.

Weight loss in Huntington disease increases with higher CAG repeat number.

Aziz NA, van der Burg JM, Landwehrmeyer GB, Brundin P, Stijnen T; EHDI Study Group, Roos RA.

Neurology. 2008 Nov 4;71(19):1506-13. doi: 10.1212/01.wnl.0000334276.09729.0e.

PMID:
18981372
[PubMed - indexed for MEDLINE]
7.

Prefrontal cortex volume reduction on MRI in preclinical Huntington's disease relates to visuomotor performance and CAG number.

Gómez-Ansón B, Alegret M, Muñoz E, Monté GC, Alayrach E, Sánchez A, Boada M, Tolosa E.

Parkinsonism Relat Disord. 2009 Mar;15(3):213-9. doi: 10.1016/j.parkreldis.2008.05.010. Epub 2008 Jul 15.

PMID:
18632301
[PubMed - indexed for MEDLINE]
8.

Tapping linked to function and structure in premanifest and symptomatic Huntington disease.

Bechtel N, Scahill RI, Rosas HD, Acharya T, van den Bogaard SJ, Jauffret C, Say MJ, Sturrock A, Johnson H, Onorato CE, Salat DH, Durr A, Leavitt BR, Roos RA, Landwehrmeyer GB, Langbehn DR, Stout JC, Tabrizi SJ, Reilmann R.

Neurology. 2010 Dec 14;75(24):2150-60. doi: 10.1212/WNL.0b013e3182020123. Epub 2010 Nov 10.

PMID:
21068430
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Intermediate CAG Repeats in Huntington's Disease: Analysis of COHORT.

Ha AD, Beck CA, Jankovic J.

Tremor Other Hyperkinet Mov (N Y). 2012;2. pii: tre-02-64-287-4. Epub 2012 Feb 2.

PMID:
23440000
[PubMed]
Free PMC Article
10.

Altered frontostriatal coupling in pre-manifest Huntington's disease: effects of increasing cognitive load.

Wolf RC, Sambataro F, Vasic N, Schönfeldt-Lecuona C, Ecker D, Landwehrmeyer B.

Eur J Neurol. 2008 Nov;15(11):1180-90. doi: 10.1111/j.1468-1331.2008.02253.x. Epub 2008 Aug 27.

PMID:
18754766
[PubMed - indexed for MEDLINE]
11.

Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat.

Ruocco HH, Bonilha L, Li LM, Lopes-Cendes I, Cendes F.

J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):130-5. Epub 2007 Jul 5.

PMID:
17615168
[PubMed - indexed for MEDLINE]
12.

Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington's disease gene carriers and healthy subjects : a cross-sectional study.

Klepac N, Relja M, Klepac R, Hećimović S, Babić T, Trkulja V.

J Neurol. 2007 Dec;254(12):1676-83. Epub 2007 Nov 9.

PMID:
17990062
[PubMed - indexed for MEDLINE]
13.

Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in Huntington's disease.

Squitieri F, Cannella M, Simonelli M, Sassone J, Martino T, Venditti E, Ciammola A, Colonnese C, Frati L, Ciarmiello A.

CNS Neurosci Ther. 2009 Winter;15(1):1-11. doi: 10.1111/j.1755-5949.2008.00068.x.

PMID:
19228174
[PubMed - indexed for MEDLINE]
14.

MRI biomarkers in Huntington's disease.

van den Bogaard S, Dumas E, van der Grond J, van Buchem M, Roos R.

Front Biosci (Elite Ed). 2012 Jan 1;4:1910-25. Review.

PMID:
22202007
[PubMed - indexed for MEDLINE]
15.

Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease.

Sturrock A, Laule C, Decolongon J, Dar Santos R, Coleman AJ, Creighton S, Bechtel N, Reilmann R, Hayden MR, Tabrizi SJ, Mackay AL, Leavitt BR.

Neurology. 2010 Nov 9;75(19):1702-10. doi: 10.1212/WNL.0b013e3181fc27e4. Erratum in: Neurology. 2011 Jan 18;76(3):309.

PMID:
21060093
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI.

Wolf RC, Vasic N, Schönfeldt-Lecuona C, Landwehrmeyer GB, Ecker D.

Brain. 2007 Nov;130(Pt 11):2845-57. Epub 2007 Sep 13.

PMID:
17855375
[PubMed - indexed for MEDLINE]
Free Article
17.

Increased brain tissue sodium concentration in Huntington's Disease - a sodium imaging study at 4 T.

Reetz K, Romanzetti S, Dogan I, Saß C, Werner CJ, Schiefer J, Schulz JB, Shah NJ.

Neuroimage. 2012 Oct 15;63(1):517-24. doi: 10.1016/j.neuroimage.2012.07.009. Epub 2012 Jul 14.

PMID:
22796981
[PubMed - indexed for MEDLINE]
18.

Stability of resting fMRI interregional correlations analyzed in subject-native space: a one-year longitudinal study in healthy adults and premanifest Huntington's disease.

Seibert TM, Majid DS, Aron AR, Corey-Bloom J, Brewer JB.

Neuroimage. 2012 Feb 1;59(3):2452-63. doi: 10.1016/j.neuroimage.2011.08.105. Epub 2011 Sep 10.

PMID:
21945695
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Rate of functional decline in Huntington's disease. Huntington Study Group.

Marder K, Zhao H, Myers RH, Cudkowicz M, Kayson E, Kieburtz K, Orme C, Paulsen J, Penney JB Jr, Siemers E, Shoulson I.

Neurology. 2000 Jan 25;54(2):452-8. Erratum in: Neurology 2000 Apr 25;54(8):1712.

PMID:
10668713
[PubMed - indexed for MEDLINE]
20.

Clinical severity of Huntington's disease does not always correlate with neuropathologic stage.

Pillai JA, Hansen LA, Masliah E, Goldstein JL, Edland SD, Corey-Bloom J.

Mov Disord. 2012 Aug;27(9):1099-103. doi: 10.1002/mds.25026. Epub 2012 Jun 1.

PMID:
22674458
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk